Drug Profile
Research programme: cyclophilin inhibitors - Hepion Pharmaceuticals
Alternative Names: 440-02; CPI-431-32Latest Information Update: 05 Aug 2019
Price :
$50
*
At a glance
- Originator Isotechnika Pharma
- Developer Aurinia Pharmaceuticals; ContraVir Pharmaceuticals
- Class Antivirals; Ciclosporins; Cyclic peptides; Hepatoprotectants; Neuroprotectants
- Mechanism of Action Cyclophilin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis B; Neurological disorders; Reperfusion injury
Most Recent Events
- 22 Jul 2019 ContraVir Pharmaceuticals is now called Hepion Pharmaceuticals
- 28 Sep 2018 Discontinued - Preclinical for Hepatitis B in Japan (PO)
- 28 Sep 2018 Discontinued - Preclinical for Hepatitis B in USA (PO)